Adherence to anti-retroviral therapy among HIV patients in Bangalore, India
Autor: | Kadappa Shivappa Satish, M. B. O’Connor, Nagendrappa Kotehalappa Praveen Kumar, Robert Laing, Mary B Cauldbeck, C. McGoldrick, Gurushanthappa Mamtha, Catherine C O'Connor, V G Mallesh, Jean Saunders, Bhimasena Rao |
---|---|
Rok vydání: | 2009 |
Předmět: |
lcsh:Immunologic diseases. Allergy
Response rate (survey) medicine.medical_specialty business.industry Research Attendance virus diseases Questionnaire Family income Treatment failure Virology Internal medicine Immunology medicine Hiv patients Molecular Medicine Pharmacology (medical) Antiretroviral medication lcsh:RC581-607 business Socioeconomic status |
Zdroj: | AIDS Research and Therapy AIDS Research and Therapy, Vol 6, Iss 1, p 7 (2009) |
ISSN: | 1742-6405 |
DOI: | 10.1186/1742-6405-6-7 |
Popis: | Introduction Human Immunodeficiency Virus (HIV) has an estimated prevalence of 0.9% in India (5.2 million). Anti-retroviral drugs (ARV) are the treatments of choice and non-adherence is an important factor in treatment failure and development of resistance, as well as being a powerful predictor of survival. This study assesses adherence to ARV in HIV positive patients in Bangalore, India, a country where only 10% of those who need therapy are receiving it. Methods A cross-sectional anonymous questionnaire survey of 60 HIV antibody positive patients was carried out with patients attending HIV outpatient services at two centres: The Chest and Maternity Centre, Rajajinagar, and Wockhardt Hospital and Heart Institute, Bangalore. Consent was obtained. Translation was done by a translator and doctors where required. Data was analysed using SPSS statistical analysis. Results A response rate of 88% (53/60) was achieved. The mean patient age was 39.98 years, with 50% aged 30–40, and 73.6% of participants being male. Mean family size was 4.8 (1–13). 21% lived less than 50 kms and 21% greater than 400 kms from clinic. 60% reported they were fully adherent. Adherence was statistically significantly linked to regular follow-up attendance (70.5%, p = 0.002). No other results were statistically significant but trends were found. "100% adherence" trends were seen in older patients, male gender, those from larger families, those who had a previous AIDS defining illness, those taking fewer tablets, and without food restrictions. Commonest side-effects causing non-adherence were metabolic reasons (66%) and GI symptoms (50%). No trends were seen for education level, family income, distance travelled to clinic, time since diagnosis, or time on ART. Conclusion Regular attendance for follow up was statistically significant for 100% lifetime adherence. Positive trends were seen in those in larger families, older, those who had AIDS defining illness, simple regimes, and without side-effects. Education, income, distance travelled and length of time diagnosed or treated had no effect on adherence. |
Databáze: | OpenAIRE |
Externí odkaz: |